From October 1, 2022 to December 31, 2022, the company has repurchased 0 shares, representing 0% for $0 million. With this, the company has completed the repurchase of 424,378,351 shares, representing 56.91% for $60,393.65 million under the buyback announced on April 21, 2011.
Market Closed -
Other stock markets
|
Pre-market 08:55:37 | |||
330.2 USD | -0.21% |
|
334.8 | +1.39% |
07-12 | Health Care Up as Momentum Builds -- Health Care Roundup | DJ |
07-12 | UBS Raises Price Target on Amgen to $337 From $307, Maintains Neutral Rating | MT |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+14.63% | 177B | |
+63.05% | 856B | |
+40.02% | 631B | |
-4.78% | 359B | |
+17.52% | 325B | |
+8.43% | 297B | |
+5.44% | 234B | |
+16.50% | 226B | |
+1.08% | 165B | |
+2.66% | 126B |
- Stock Market
- Equities
- AMGN Stock
- News Amgen Inc.
- Tranche Update on Amgen Inc.'s Equity Buyback Plan announced on April 21, 2011.